Skip to main content
SpringerLink
Log in

Parathyroid Disease: Incidence, Diagnosis, and Management Internationally

  • Chapter
  • First Online:
Medical and Surgical Treatment of Parathyroid Diseases

  • 1019 Accesses

Abstract

The parathyroid glands regulate calcium metabolism through release of parathyroid hormone (PTH). Because most parathyroid disorders present with abnormalities of serum calcium, they commonly appear in differential diagnoses [1]. Based on that, every patient with a calcium abnormality should be investigated for parathyroid disorders. Moreover, the prevalence of parathyroid diseases is still unclear in some environments, and understanding the diagnosis and treatment of parathyroid disorders is very important for the head and neck surgeon.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Michels TC, Kelly KM. Parathyroid disorders. Am Fam Physician. 2013;88(4):249–57. Clinical Review; Level 2; Grade A–B.

    PubMed  Google Scholar 

  2. Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008;359(4):391–403. Clinical Review; Level 3; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  3. Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. The epidemiology of non-surgical hypoparathyroidism in Denmark: a nationwide case finding study. J Bone Miner Res. 2015;30(9):1738–44. Population/Observational Study; Level 2; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  4. Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145–58. Clinical Review; Level 2; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  5. Nakamura Y, Matsumoto T, Tamakoshi A, et al. Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol. 2000;10(1):29–33. Population/Observational Study; Level 2; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  6. Bilezikian JP, Khan A, Potts JT, et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011;26(10):2317–37. Clinical Review; Level 2; Grade A–B.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. McGinn JD. Prevention of complications in revision endocrine surgery of the head & neck. Otolaryngol Clin North Am. 2008;41(6):1219–30. xi, Clinical Investigation; Level 3; Grade A–B.

    Article  PubMed  Google Scholar 

  8. Edafe O, Antakia R, Laskar N, Uttley L, Balasubramanian SP. Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br J Surg. 2014;101(4):307–20. Clinical Review; Level 2; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  9. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O’Fallon WM, Melton 3rd LJ. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med. 1997;126(6):433–40. Population/Observational Study; Level 3; Grade A–B.

    Google Scholar 

  10. Pallan S, Khan A. Primary hyperparathyroidism: update on presentation, diagnosis, and management in primary care. Can Fam Physician. 2011;57(2):184–9. Clinical Review; Level 3; Grade A–B.

    PubMed  PubMed Central  Google Scholar 

  11. AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005;11(1):49–54. Clinical Review; Level 2; Grade A–B.

    Article  Google Scholar 

  12. Kirdak T, Duh QY, Kebebew E, Clark OH. Do patients undergoing parathyroidectomy for primary hyperparathyroidism in San Francisco, CA, and Bursa, Turkey, differ? Am J Surg. 2009;198(2):188–92. Population/Observational Study; Level 2; Grade A–B.

    Article  PubMed  Google Scholar 

  13. Palmer M, Jakobsson S, Akerstrom G, Ljunghall S. Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest. 1988;18(1):39–46. Population/Observational Study; Level 2; Grade A.

    Article  CAS  PubMed  Google Scholar 

  14. Rankin J, Espiner EA, Hinton D, Holland GW. Primary hyperparathyroidism in a New Zealand community: a review of 40 cases. N Z Med J. 1979;90(639):1–4. Clinical Review; Level 3; Grade A–B.

    CAS  PubMed  Google Scholar 

  15. Cheung PS, Boey JH, Wang CC, Ma JT, Lam KS, Yeung RT. Primary hyperparathyroidism: its clinical pattern and results of surgical treatment in Hong Kong Chinese. Surgery. 1988;103(5):558–62. Population/Observational Study; Level 2; Grade A–B.

    CAS  PubMed  Google Scholar 

  16. Niederle B, Stamm L, Langle F, Schubert E, Woloszczuk W, Prager R. Primary hyperparathyroidism in Austria: results of an 8-year prospective study. World J Surg. 1992;16(4):777–82. discussion 82-3, Population/Observational Study; Level 2; Grade A.

    Article  CAS  PubMed  Google Scholar 

  17. Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet. 1980;1(8182):1317–20. Clinical Review; Level 2; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  18. Stenstrom G, Heedman PA. Clinical findings in patients with hypercalcaemia. A final investigation based on biochemical screening. Acta Med Scand. 1974;195(6):473–7. Clinical Investigation; Level 3; Grade A–B.

    CAS  PubMed  Google Scholar 

  19. Kebebew E, Clark OH. Parathyroid adenoma, hyperplasia, and carcinoma: localization, technical details of primary neck exploration, and treatment of hypercalcemic crisis. Surg Oncol Clin N Am. 1998;7(4):721–48. Population/Observational Study; Level 2; Grade A–B.

    CAS  PubMed  Google Scholar 

  20. Miller BS, Dimick J, Wainess R, Burney RE. Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg. 2008;32(5):795–9. Population/Observational Study; Level 2; Grade A–B.

    Article  PubMed  Google Scholar 

  21. Siilin H, Lundgren E, Mallmin H, et al. Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden. World J Surg. 2011;35(6):1266–72. Population/Observational Study; Level 3; Grade A–B.

    Article  PubMed  Google Scholar 

  22. Jorde R, Bonaa KH, Sundsfjord J. Primary hyperparathyroidism detected in a health screening. The Tromso study. J Clin Epidemiol. 2000;53(11):1164–9. Population/Observational Study; Level 2; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  23. Pradeep PV, Jayashree B, Mishra A, Mishra SK. Systematic review of primary hyperparathyroidism in India: the past, present, and the future trends. Int J Endocrinol. 2011;2011:921814. Clinical Review; Level 3; Grade A–B.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ruda JM, Hollenbeak CS, Stack Jr BC. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngology. 2005;132(3):359–72. Clinical Review; Level 3; Grade A–B.

    Google Scholar 

  25. Toursarkissian B, Sloan DA, Schwartz RW. Coexisting hyperthyroidism and primary hyperparathyroidism. Surgery. 1993;113(6):716–8. Clinical Investigation; Level 3; Grade B.

    CAS  PubMed  Google Scholar 

  26. Abboud B, Sleilaty G, Mansour E, et al. Prevalence and risk factors for primary hyperparathyroidism in hyperthyroid patients. Head Neck. 2006;28(5):420–6. Clinical Review; Level 2; Grade A–B.

    Article  PubMed  Google Scholar 

  27. Paruk IM, Esterhuizen TM, Maharaj S, Pirie FJ, Motala AA. Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience. Postgrad Med J. 2013;89(1057):626–31. Population/Observational Study; Level 2; Grade A.

    Article  CAS  PubMed  Google Scholar 

  28. Sharretts JM, Kebebew E, Simonds WF. Parathyroid cancer. Semin Oncol. 2010;37(6):580–90. Clinical Review; Level 3; Grade A–B.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Dudney WC, Bodenner D, Stack Jr BC. Parathyroid carcinoma. Otolaryngol Clin North Am. 2010;43(2):441–53. xi, Clinical Review; Level 2; Grade A–B.

    Article  PubMed  Google Scholar 

  30. Kebebew E. Parathyroid carcinoma. Curr Treat Options Oncol. 2001;2(4):347–54. Clinical Review; Level 2; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  31. Kebebew E, Arici C, Duh QY, Clark OH. Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg. 2001;136(8):878–85. Clinical Investigation; Level 2; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  32. Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007;109(9):1736–41. Population/Observational Study; Level 2; Grade A–B.

    Article  PubMed  Google Scholar 

  33. Wei CH, Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol. 2012;13(1):11–23. Clinical Review; Level 3; Grade A–B.

    Article  PubMed  Google Scholar 

  34. Bae JH, Choi HJ, Lee Y, et al. Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism. J Korean Med Sci. 2012;27:890–5. Clinical Investigation; Level 3; Grade B.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Favia G, Lumachi F, Polistina F, D’Amico DF. Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg. 1998;22(12):1225–30. Population/Observational Study; Level 4.

    Google Scholar 

  36. Lee YS, Hong SW, Jeong JJ, et al. Parathyroid carcinoma: a 16-year experience in a single institution. Endocr J. 2010;57(6):493–7. Clinical Investigation; Level 3; Grade B.

    Article  PubMed  Google Scholar 

  37. Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg. 1991;15(6):738–44. Clinical Review; Level 3; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  38. Sandelin K, Thompson NW, Bondeson L. Metastatic parathyroid carcinoma: dilemmas in management. Surgery. 1991;110(6):978–86. discussion 86–8, Clinical Review; Level 4.

    CAS  PubMed  Google Scholar 

  39. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine. 1992;71(4):197–205. Clinical Review; Level 3; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  40. Mohebati A, Shaha A, Shah J. Parathyroid carcinoma: challenges in diagnosis and treatment. Hematol Oncol Clin North Am. 2012;26(6):1221–38. Clinical Review; Level 2; Grade A–B.

    Article  PubMed  Google Scholar 

  41. Sadler C, Gow KW, Beierle EA, et al. Parathyroid carcinoma in more than 1,000 patients: a population-level analysis. Surgery. 2014;156(6):1622–9. discussion 9–30, Population/Observational Study; Level 3; Grade A–B.

    Article  PubMed  Google Scholar 

  42. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86(12):5658–71. Clinical Review; Level 2; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  43. Giusti F, Cavalli L, Cavalli T, Brandi ML. Hereditary hyperparathyroidism syndromes. J Clin Densitom. 2013;16(1):69–74. Clinical Review; Level 2; Grade A–B.

    Article  PubMed  Google Scholar 

  44. Sakurai A, Suzuki S, Kosugi S, et al. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database. Clin Endocrinol (Oxf). 2012;76(4):533–9. Population/Observational Study; Level 3; Grade A–B.

    Article  Google Scholar 

  45. Howe JR, Norton JA, Wells Jr SA. Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up. Surgery. 1993;114(6):1070–7. Population/Observational Study; Level 2; Grade A–B.

    CAS  PubMed  Google Scholar 

  46. Rahimian M, Sami R, Behzad F. Evaluation of secondary hyperparathyroidism in patients undergoing hemodialysis. Saudi J Kidney Dis Transpl. 2008;19(1):116–9. Clinical Review; Level 3; Grade B.

    PubMed  Google Scholar 

  47. Oliveira RB, Silva EN, Charpinel DM, Gueiros JE, Neves CL, Sampaio Ede A, et al. Secondary hyperparathyroidism status in Brazil: Brazilian census of parathyroidectomy. J Bras Nefrol. 2011;33(4):457–62. Clinical Review; Level 3; Grade A–B.

    Article  PubMed  Google Scholar 

  48. Young EW, Albert JM, Satayathum S, et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005;67(3):1179–87. Population/Observational Study; Level 3; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  49. Kramer P, Broyer M, Brunner FP, et al. Combined report on regular dialysis and transplantation in Europe, XIV, 1983. Proceedings of the European Dialysis and Transplant Association—European Renal Association European Dialysis and Transplant Association—European Renal Association Congress. 1985;21:2–65, Clinical Review; Level 2; Grade A–B.

    Google Scholar 

  50. Hedgeman E, Lipworth L, Lowe K, Saran R, Do T, Fryzek J. International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data. Int J Nephrol. 2015;2015:184321. Clinical Review; Level 2; Grade A–B.

    Article  PubMed  PubMed Central  Google Scholar 

  51. van Schoor NM, Lips P. Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab. 2011;25(4):671–80. Clinical Review; Level 2; Grade A–B.

    Article  PubMed  Google Scholar 

  52. Gomez-Alonso C, Naves-Diaz ML, Fernandez-Martin JL, Diaz-Lopez JB, Fernandez-Coto MT, Cannata-Andia JB. Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int Suppl. 2003;85:S44–8. Clinical Review; Level 2; Grade A–B.

    Article  CAS  Google Scholar 

  53. Scharla SH. Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporos Int. 1998;8 Suppl 2:S7–12. Population/Observational Study; Level 3; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  54. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338(12):777–83. Clinical Investigation; Level 3; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  55. van der Wielen RP, Lowik MR, van den Berg H, et al. Serum vitamin D concentrations among elderly people in Europe. Lancet. 1995;346(8969):207–10. Population/Observational Study; Level 3; Grade A–B.

    Article  PubMed  Google Scholar 

  56. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab. 2001;86(3):1212–21. Clinical Investigation; Level 1; Grade B.

    Article  CAS  PubMed  Google Scholar 

  57. Harris SS, Soteriades E, Dawson-Hughes B, Framingham Heart S, Boston Low-Income Elderly Osteoporosis Study. Secondary hyperparathyroidism and bone turnover in elderly blacks and whites. J Clin Endocrinol Metab. 2001;86(8):3801–4. Clinical Investigation; Level 2; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  58. Ghazali A, Fardellone P, Pruna A, et al. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser’s zones independent of calcitriol? Kidney Int. 1999;55(6):2169–77. Clinical Investigation; Level 2; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  59. Meyer HE, Falch JA, Sogaard AJ, Haug E. Vitamin D deficiency and secondary hyperparathyroidism and the association with bone mineral density in persons with Pakistani and Norwegian background living in Oslo, Norway. The Oslo Health Study. Bone. 2004;35(2):412–7. Population/Observational Study; Level 2; Grade A–B.

    Article  CAS  PubMed  Google Scholar 

  60. Saraiva GL, Cendoroglo MS, Ramos LR, Araujo LM, Vieira JG, Maeda SS, et al. Prevalence of vitamin D deficiency, insufficiency and secondary hyperparathyroidism in the elderly inpatients and living in the community of the city of Sao Paulo, Brazil. Arq Bras Endocrinol Metabol. 2007;51(3):437–42. Population/Observational Study; Level 3; Grade A–B.

    Article  PubMed  Google Scholar 

  61. Gayed IW, Kim EE, Broussard WF, et al. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med. 2005;46(2):248–52. Population/Observational Study; Level 2; Grade A–B.

    PubMed  Google Scholar 

  62. Johnson LR, Doherty G, Lairmore T, et al. Evaluation of the performance and clinical impact of a rapid intraoperative parathyroid hormone assay in conjunction with preoperative imaging and concise parathyroidectomy. Clin Chem. 2001;47(5):919–25. Clinical Investigation; Level 2; Grade A–B.

    CAS  PubMed  Google Scholar 

  63. Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, Wang CA. Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery. 1988;104(6):1121–7. Clinical Investigation; Level 3; Grade A–B.

    CAS  PubMed  Google Scholar 

  64. Taylor J, Fraser W, Banaszkiewicz P, Drury P, Atkins P. Lateralization of parathyroid adenomas by intra-operative parathormone estimation. J R Coll Surg Edinb. 1996;41(3):174–7. Clinical Investigation; Level 3; Grade A–B.

    CAS  PubMed  Google Scholar 

  65. Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140(5):472–8. discussion 8-9, Clinical Review; Level 2; Grade A–B.

    Article  PubMed  Google Scholar 

  66. Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery. 2004;136(4):872–80. Clinical Investigation; Level 3; Grade A–B.

    Article  PubMed  Google Scholar 

  67. Magnabosco FF, Tavares MR, Montenegro FL. Surgical treatment of secondary hyperparathyroidism: a systematic review of the literature]. Arq Bras Endocrinol Metabol. 2014;58(5):562–71. Clinical Review; Level 2; Grade A–B.

    Article  PubMed  Google Scholar 

  68. Sitges-Serra A, Girvent M, Pereira JA, et al. Bone mineral density in menopausal women with primary hyperparathyroidism before and after parathyroidectomy. World J Surg. 2004;28(11):1148–52. Clinical Investigation; Level 3; Grade A–B.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Head and Neck Surgery, University of São Paulo Medical School, São Paulo, Brazil

    Claudio Roberto Cernea M.D., Ph.D., Leandro Luongo de Matos M.D., Ph.D. & Evandro Lima e Silva M.D.

  2. Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul, 133-792, South Korea

    Kyung Tae M.D., Ph.D.

Authors
  1. Claudio Roberto Cernea M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyung Tae M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leandro Luongo de Matos M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Evandro Lima e Silva M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA

    Brendan C. Stack, Jr.

  2. Department of Geniatrics and Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA

    Donald L. Bodenner

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Cernea, C.R., Tae, K., de Matos, L.L., e Silva, E.L. (2017). Parathyroid Disease: Incidence, Diagnosis, and Management Internationally. In: Stack, Jr., B., Bodenner, D. (eds) Medical and Surgical Treatment of Parathyroid Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-26794-4_45

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26794-4_45

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26792-0

  • Online ISBN: 978-3-319-26794-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation